Genes Don't Cause Racial-Health Disparities, Society Does
By Jason Silverstein,
The Atlantic
| 04. 13. 2015
Untitled Document
On April 24, 2003, shortly after the completion of the human genome project, its director Francis Collins and his team posed 15 grand challenges to the scientific community. They dared researchers to harness the genome to crack puzzles of biology, health, and society. In particular, they called for genome-based tools to close health disparities. Since then, the United States has pumped more than $1 billion a year into genomics research. What do we have to show for it?
“What we found in the literature published from 2007 to 2013 was basically nothing,” said Jay Kaufman, the lead author of the first study to examine available genetic data for evidence that explains a major racial-health disparity. For many years, researchers speculated that what they couldn’t explain about disparities must be the fingerprint of some mysterious genetic component. But since they are now able to scan the entire genome, this speculation appears both lazy and wrong. When it comes to why many black people die earlier than white people in the U.S., Kaufman and his colleagues show we've been...
Related Articles
By Neel Shah, The PrePrint | 04.11.2024
Years ago, I interviewed for a residency position at The Johns Hopkins Hospital in Baltimore. Standing before the domed Victorian building at the campus entrance, I couldn’t help but be in awe of the history of the place, the great...
By Rob Stein, NPR | 03.07.2024
A big federal research project aimed at reducing racial disparities in genetic research has unveiled the program's first major trove of results.
"This is a huge deal," says Dr. Joshua Denny, who runs the All of Us program at...
By Max Kozlov, Nature | 02.23.2024
Some geneticists have expressed their unease about a figure in a high-profile Nature paper that was published earlier this week1, noting that it could be misinterpreted as reinforcing racist beliefs. The figure has reignited a long-standing debate among...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...